Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on June 24, 2025

SecureTech Acquires 100% of AI UltraProd Group in Landmark Deal
First Transformative Achievement Under Our Mergers …

CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer
VANCOUVER, Washington, June 24, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that …

Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation
--During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study; on average, enobosarm 3mg significantly reduced body …

TerraZero Technologies Launches Wave of Groundbreaking Artist Activations, Introducing New Firsts in Intraverse Music Experiences
VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”)(TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of TerraZero, Netcoins and Blockchain …

ARK Demonstrates Robust June Momentum as Snail Games Celebrates 10-Year Anniversary and Prepares for Aquatica DLC Launch
ARK: Survival Evolved sees over 3,000% sales lift in June Snail leverages box office and music partnerships to promote ARK: Aquatica CULVER CITY, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a …

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market
Strategic Acquisition Brings Patented Implant Designs, Seasoned Executive Team, and Near-Term Commercial Opportunities SALT LAKE CITY, Utah, June 24, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced …

DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (“DSS” or the “Company”), a multinational company operating across diverse industries including packaging, wealth management, and biohealth innovation, today announced that its …

Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC)
Good Tolerability and Robust Tumor Uptake were Observed in TNBC Animal Models Auger Emitters Offer the Potential Benefit of Enhanced Cytotoxicity, Safety and Ease-of-Use FLORHAM PARK, N.J., June 24, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. ( …

Primech AI, a Subsidiary of Primech Holdings, Expands to the Hong Kong Market Through a Strategic Partnership with ReMining Ai Ltd.
SINGAPORE, June 24, 2025 (GLOBE NEWSWIRE) -- Primech AI Pte. Ltd. (“Primech AI” or the “Company”), a subsidiary of Primech Holdings Limited (Nasdaq: PMEC), today announced the signing of a strategic partnership with Hong Kong-based ReMining Ai Ltd to …

Miata Metals Begins Drilling at Puma Target Following High Grade Surface Results on Sela Creek Gold Project
VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- Miata Metals Corp. (CSE: MMET) (FSE: 8NQ) (OTCQB:MMETF) (“Miata” or the “Company”) is pleased to announce that it has begun its planned drill test of the Puma Target. This follows the …

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics
Vancouver, Canada, June 24, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
RAD 402 preclinical data package complete; demonstrates safety and promising biodistribution profile Ethics approval and Phase 1 clinical trial start in prostate cancer anticipated in 2H 2025 SYDNEY and BUNDOORA, Australia, June 24, 2025 (GLOBE NEWSWIRE) …

Celebrate Innovation in Education at ISTELive 25 with zSpace
SAN JOSE, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- zSpace (NASDAQ: ZSPC) (“zSpace” or the “Company”), a leading provider of augmented and virtual reality solutions for education, today announced its participation in the ISTE Live 25 Conference, taking …

SIOS Technology Announces Strategic Partnership with FCS InfoTech to Deliver High Availability and Disaster Recovery Solutions Across India and the GCC Region
SAN MATEO, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- SIOS Technology Corp., a leading provider of application high availability (HA) and disaster recovery (DR) solutions, today announced a strategic partnership with FCS InfoTech, a rapidly growing IT …

Starton Therapeutics and Bend Bioscience Enter into Development Agreement for Oral Controlled Release Dosage Form of STAR-LLD (lenalidomide)
PARAMUS, N.J., June 24, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technologies, today announced a collaboration …

ClearScale Appoints Matt Stoyka as CEO, Names Jimmy Chui Chief Client Officer
SAN FRANCISCO, June 24, 2025 (GLOBE NEWSWIRE) -- ClearScale, a leader in cloud modernization and an Amazon Web Services (AWS) Premier Tier Services Partner, today announced a leadership transition designed to accelerate growth and deepen client …

Byrna Technologies to Report Fiscal Second Quarter 2025 Financial Results on Thursday, July 10, 2025 at 9:00 a.m. ET
ANDOVER, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security …

Medera’s Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart Syndrome
First-ever mini-Heart models will be created from hypoplastic left heart syndrome (HLHS) patient stem cells, enabling personalized insights into their causes and treatments Partnership aims to improve survival and quality of life for pediatric HLHS …

SELLAS Life Sciences to be Added to Russell 3000® and Russell 2000® Indexes
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …

Pioneering New Study Finds Most U.S. Babies Lack Key Gut Bacteria, Increasing Risk for Allergies and Other Chronic Health Issues
Initial findings published today in Communications Biology - a Nature portfolio journal - show that 76% of infants in the U.S. are deficient in Bifidobacterium, a gut microbiome genus responsible for the utilization of human milk oligosaccharides (HMOs) …